Close
Show

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

Personalised Medicine and Diagnostics Europe 2011


Innovate in an era of cost-effectiveness: Realise the value of personalised medicine Discover how...

King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY


King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. announced that King has resubmitted a New Drug...

Sanofi-aventis Acquires from Ascendis Pharma Worldwide Rights on Drug-Delivery


Sanofi-aventis and Ascendis Pharma (Ascendis) announced a global licensing and patent transfer agreement on Ascendis’...

Bristol-Myers Squibb Company and Pfizer Inc.announced that the ADVANCE-3 study results


Bristol-Myers Squibb Company and Pfizer Inc.announced that the ADVANCE-3 study results, published in The New...

Novartis drug Tasigna approved in Japan for treatment of patients with newly diagnosed Ph+...


Novartis has received approval from Japan's Ministry of Health, Labour and Welfare to offer Tasigna®...

Lilly Announces Completion of Avid Acquisition and FDA Priority Review for florbetapir


Eli Lilly and Company announced that it has completed the acquisition of Avid Radiopharmaceuticals, Inc.,...

Merck KGaA and sanofi-aventis Sign Agreement to Jointly Investigate Novel Combinations Against Cancer


Merck KGaA announced today that it has signed a worldwide research and development agreement with...

Malaria Vaccine Initiative, Merck and NYU Langone Medical Center Collaborate to Research Potential Malaria...


Development of a vaccine to prevent the malaria parasite from entering the human liver is...

New subgroup analysis of the LUX-Lung 1 trial suggests benefit from afatinib in lung...


New data to be presented show that afatinib (BIBW 2992) leads to a significant four-fold...

The R and D Leaders Band Together at Discovery Summit 2011 to Uncover Innovative...


The Discovery Summit 2011, presented by marcus evans, will be taking place from 21-23 March...